Call Buying Activity in Elanco Animal Health (ELAN) Targets Upside in Shares Through March -Susquehanna
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
UPDATE: Credit Suisse Upgrades Elanco Animal Health (ELAN) to Outperform
February 26, 2021 4:39 AM EST(Updated - February 26, 2021 5:27 AM EST)
Credit Suisse analyst Erin Wilson Wirght upgraded Elanco Animal Health (NYSE: ELAN) from Neutral to Outperform with a price target of $38.00 (from $33.00).
The analyst comments "e are upgrading Elanco (ELAN) to Outperform (from Neutral) on incremental... More
Elanco Animal Health (ELAN) Tops Q4 EPS by 3c, Offers Guidance
February 24, 2021 6:40 AM ESTElanco Animal Health (NYSE: ELAN) reported Q4 EPS of $0.12, $0.03 better than the analyst estimate of $0.09. Revenue for the quarter came in at $1.14 billion versus the consensus estimate of $1.06 billion.
GUIDANCE:
Elanco Animal Health sees Q1 2021 EPS of $0.20-$0.25, versus the... More
